Michael Scolaro

Michael Scolaro

Sep 01, 2017

Group 6 Copy 123
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can cockroaches help us cure tularemia?

    Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

    Affordable 3D-Printed Neural Devices for Spinal Cord Regeneration

    Medical treatments for spinal cord injuries are expensive and difficult to test. I want to try to develop a...

    Improving Collaborations for Neglected Tropical Diseases

    Neglected tropical diseases (NTDs) infect over a billion of the poorest people in the world, yet only a tiny...

    Backer Badge Funded